vimarsana.com

Page 2 - விசை இரசாயன தொகுப்பு அடிப்படையிலானது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aarti Drugs share rises 8% after arm gets nod under pharma PLI scheme

Aarti Drugs share rises 8% after arm gets nod under pharma PLI scheme Aarti Drugs share touched an intraday high of Rs 717.85 rising 7.83% against previous close of Rs 665.70 on BSE BusinessToday.In | March 8, 2021 | Updated 14:56 IST Aarti Drugs stock trades higher than 5 day, 20 day, 50 day and 200 day moving averages but lower than 100 day moving averages. Aarti Drugs share rose nearly 8% today after the company s subsidiary received approval under Production Linked Incentive (PLI) scheme for the pharmaceutical sector. The pharma stock opened with a gain of 6.11% at Rs 706.35 today. The mid cap stock touched an intraday high of Rs 717.85 rising 7.83% against previous close of Rs 665.70 on BSE.

Sensex closes almost flat, Nifty fails to reclaim 15,000

Read more about Sensex closes almost flat, Nifty fails to reclaim 15,000 on Business Standard. Domestic equity benchmarks ended with small gains on Monday. Banks, IT, metals and pharma stocks advanced while autos, financials and FMCG shares declined. The Nifty closed near the 15,000 mark.

Stocks to track in trade for March 8, 2021: India Grid Trust, Adani Ports, Maruti Suzuki, Indian Bank, BEML

Stocks to track in trade for March 8, 2021: India Grid Trust, Adani Ports, Maruti Suzuki, Indian Bank, BEML
timesnownews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from timesnownews.com Daily Mail and Mail on Sunday newspapers.

Aarti Speciality Chemicals Limited receives an approval accorded under PLI Scheme for Pharmaceutical Sector

Aarti Speciality Chemicals Limited receives an approval accorded under PLI Scheme for Pharmaceutical Sector Posted On: 2021-03-06 04:25:29 (Time Zone: Arizona, USA) Aarti Speciality Chemicals Limited (ASCL), a wholly-owned subsidiary of Aarti Drugs Limited (Aarti Drugs), stands out to be one of the beneficiaries of the Government of India s recently approved Production Linked Incentive (PLI) for the Pharmaceutical Sector. Government of India s Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers recently launched a Production Linked Incentive (PLI) Scheme to promote domestic manufacturing by incentivising pharmaceutical manufacturers to set-up greenfield projects in India with a minimum domestic value addition in four different target segments (Two in Fermentation based - at least 90% and Two in the Chemical Synthesis based - at least 70%) with a total outlay of Rs. 6,940 crores. The objective of the scheme is achieving self-reliance and reducing im

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.